UK markets closed

Circio Holding ASA (0RIS.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
11.20+0.08 (+0.69%)
At close: 04:10PM BST

Circio Holding ASA

St. Olavs Plass 5
Oslo 0165
47 92 95 17 88

Full-time employees9

Key executives

NameTitlePayExercisedYear born
Dr. Erik Digman WiklundChief Executive Officer2.6MN/AN/A
Dr. Lubor Gaal Ph.D.Chief Financial Officer2.88MN/A1968
Mr. Ola MelinChief Operating Officer1.97MN/AN/A
Dr. Thomas Birkballe HansenChief Technology Officer1.97MN/AN/A
Dr. Victor Levitsky M.D., Ph.D.Chief Scientific Officer790kN/AN/A
Mr. Jon Amund Eriksen M.Sc., MScSpecial Advisor1.86MN/AN/A
Prof. Gustav Gaudernack Ph.D.Chief Scientific AdviserN/AN/AN/A
Dr. Peter Skorpil Ph.D.Vice President of Business Development1.07MN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.


Circio Holding ASA, a biotechnology company developing novel circular RNA and immunotherapy medicines. Its lead product candidate is ONCOS-102 for the treatment of mesothelioma and melanoma; TG01 KRAS immunotherapy neoantigen therapeutic anti-cancer vaccine. The company is also developing TG-01, a cancer vaccine program targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette designed for efficient biogenesis of multifunctional circRNAs in human cells. The company has collaboration agreement with the University of Kansas Cancer Center; Oslo University Hospital; and with Janssen and Bristol Myers Squibb. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. Circio Holding ASA was incorporated in 2010 and is based in Oslo, Norway.

Corporate governance

Circio Holding ASA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.